Joshua Brody, Associate Professor of Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared on LinkedIn:
“Great, crystal-clear update on treating aggressive lymphomas e.g. DLBCL in Community Oncology centers and opportunities for collaboration with Lymphoma specialists. ”